🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the vaccine efficacy, immunogenicity and...
Status
Recruiting
Location
Liuzhou center for disease control and prevention
Start Date
2020-04-28
Trial ID
NCT04422366
A total of 480 Chinese women aged 18-26 years old were enrolle，experimental...
Status
Completed
Location
Liucheng Center for Disease Control and Prevention
Start Date
2020-06-20
Trial ID
NCT04436133
The study will evaluate the immunogenicity and safety of 9-valent HPV recom...
Status
Completed
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2020-09-19
Trial ID
NCT05372016
A total of 90 Chinese women aged 9-45 years old were divided into three age...
Status
Completed
Location
Liuzhou Center for Disease Control and Prevention
Start Date
2019-09-07
Trial ID
NCT04083196
Treatments Being Tested
The study will evaluate the immunogenicity and safety of 4-valent and 9-val...
Status
Completed
Location
Yangchun Center For Disease Prevention And Control
Start Date
2020-05-28
Trial ID
NCT04425291
Treatments Being Tested
This phase 3 study will evaluate the immunogenicity and safety of 9-valent ...
Status
Unknown
Location
Huakun Lv
Start Date
2021-05-28
Trial ID
NCT04895020
Treatments Being Tested
A total of 13500 Chinese women aged 18-45 years old were divided into three...
Status
Recruiting
Location
Hechi Yizhou District Center for Disease Control and Prevention
Start Date
2022-06-04
Trial ID
NCT05262010
Treatments Being Tested
This study is designed to evaluate the vaccine efficacy, immunogenicity and...
Status
Active Not Recruiting
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2024-07-11
Trial ID
NCT06465914
To evaluate the safety and immunogenicity of the 9-valent Human Papillomavi...
Status
Completed
Location
Zhejiang Provincial Center for Disease Control and Prevention
Start Date
2018-10-10
Trial ID
NCT03676101
Treatments Being Tested